drugset / Trial / NCT00499967

Safety and Effectiveness Study of an Experimental Topical Ointment (GS-9191) for the Treatment of Genital Warts

NCT00499967 ↗

Phase 1 Completed 202 enrolled Gilead Sciences
RandomizedParallel-groupTriple-blindTreatment

Summary

The purpose of this study is to assess the safety, tolerability and activity of GS-9191 ointment in the treatment of genital warts. GS-9191 ointment is intended for topical application directly to genital warts on the skin.

Timeline

Start
2007-08
Primary completion
2009-02
Completion
2009-03

Drugs

EvaluationDrugModalityDoseRoute
Subject GS-9191 Small molecule 0.01 % Topical
Subject GS-9191 Small molecule 0.03 % Topical
Subject GS-9191 Small molecule 0.1 % Topical
Subject GS-9191 Small molecule 0.3 % Topical
Subject GS-9191 Small molecule 1 % Topical